DNA Structure, Replication, And Repair — Molecular Biology – DNA Structure, Replication, And Repair - USMLE Step 1

SECTION 1

Historical Context & Motivation

The quest to understand heredity at the molecular level began long before the iconic double helix graced the cover of Nature in 1953. Friedrich Miescher first isolated a phosphorus-rich substance from the nuclei of white blood cells in 1869, which he called nuclein — what we now recognize as DNA. For decades, most biochemists considered proteins, with their twenty distinct amino acids, to be the only molecules complex enough to carry genetic instructions. It was not until a series of elegant experiments in the mid-twentieth century that DNA was definitively established as the molecule of heredity, fundamentally reshaping our understanding of biology and disease.

1928 • Griffith's Transformation Experiment

Frederick Griffith demonstrated that a 'transforming principle' could convert non-virulent pneumococci into virulent forms, hinting that genetic material could be transferred between organisms.

1944 • Avery–MacLeod–McCarty Experiment

Oswald Avery and colleagues showed that purified DNA — not protein or RNA — was the transforming principle, providing the first biochemical evidence that DNA carries genetic information.

1950 • Chargaff's Rules

Erwin Chargaff discovered that in any species' DNA, the amount of adenine equals thymine and the amount of guanine equals cytosine (A = T; G = C), establishing the concept of base pairing.

1952 • Hershey–Chase Experiment

Using radioactive phosphorus (³²P) and sulfur (³⁵S) to label bacteriophage DNA and protein respectively, Alfred Hershey and Martha Chase confirmed that DNA, not protein, enters host cells during infection.

1953 • Watson & Crick Double Helix

James Watson and Francis Crick, building on Rosalind Franklin's X-ray crystallography data, proposed the double-helical structure of DNA, immediately suggesting a mechanism for faithful replication.

The discovery of the double helix answered one critical question — how genetic information is stored — but opened many more. How is the helix unwound and copied with extraordinary fidelity before each cell division? What happens when the copying machinery makes a mistake, or when environmental agents damage the template? Understanding these processes is not merely an academic exercise: defects in DNA replication and DNA repair underlie numerous human diseases, from hereditary cancer syndromes to premature aging disorders, making this topic indispensable for future clinicians.

SECTION 2

Core Principles of DNA Structure

DNA is a polymer of deoxyribonucleotides, each composed of three components: a five-carbon deoxyribose sugar, a phosphate group, and one of four nitrogenous bases. The two purine bases — adenine (A) and guanine (G) — contain a fused bicyclic ring, while the two pyrimidine bases — cytosine (C) and thymine (T) — have a single ring. The sugar-phosphate backbone runs in an antiparallel fashion: one strand extends 5′ → 3′ while its complement runs 3′ → 5′, and this directionality has profound implications for replication enzymology.

Antiparallel Strands

The two DNA strands run in opposite directions. The 5′-end has a free phosphate group and the 3′-end has a free hydroxyl group. DNA polymerases can only synthesize in the 5′ → 3′ direction.

Complementary Base Pairing

A pairs with T via 2 hydrogen bonds; G pairs with C via 3 hydrogen bonds. GC-rich regions are more thermally stable and require more energy to denature.

Major & Minor Grooves

The helical twist creates asymmetric grooves on the DNA surface. Regulatory proteins and transcription factors typically recognize sequences through the major groove, which exposes more chemical information.

B-DNA Is the Physiological Form

Under physiological conditions, DNA adopts the B-form: a right-handed helix with ~10.4 bp per turn and 3.4 nm pitch. A-DNA (dehydrated) and Z-DNA (left-handed, GC-rich) are alternative conformations with clinical relevance in autoimmune disease.

✦

KEY TAKEAWAY

Think of DNA's two strands like a zipper with two different colored tapes running in opposite directions. The teeth interlock precisely — A always with T, G always with C — so if you know one side, you can reconstruct the other. This built-in redundancy is exactly how the cell achieves high-fidelity replication: each strand serves as a template for its partner, much like a photographic negative can recreate the original image.

SECTION 3

Visual Explanation: DNA Double Helix & Nucleotide Structure

Left: The double helix illustrating antiparallel strands with complementary base pairing (A=T with 2 H-bonds, G≡C with 3 H-bonds). Note the 5′ and 3′ designations run in opposite directions. Right: The three components of a nucleotide — phosphate, deoxyribose sugar, and nitrogenous base — with the purine/pyrimidine classification.

Examine the diagram carefully. On the left, the two sugar-phosphate backbones (cyan and pink) twist around a common axis, with dashed horizontal lines representing the hydrogen bonds between complementary base pairs. The 5′ → 3′ polarity of the left strand runs top-to-bottom, while the right strand runs bottom-to-top, illustrating the antiparallel nature of DNA. On the right panel, each nucleotide is deconstructed into its three building blocks. A critical clinical point emerges from the sugar component: deoxyribose lacks a hydroxyl group at the 2′ position, which renders DNA more resistant to alkaline hydrolysis than RNA — a distinction that matters when interpreting molecular assays in the clinical laboratory.

💡

HIGH-YIELD MNEMONIC

Remember base-pair hydrogen bonds: A-T = 2 hydrogen bonds (the letters A and T each have 2 straight lines), while G-C = 3 hydrogen bonds (the letter C has 3 curves). GC-rich regions have a higher melting temperature (T_m) because more energy is needed to break those extra bonds.

SECTION 4

DNA Replication Machinery

DNA replication in eukaryotes is a semiconservative process, as demonstrated by the classic Meselson–Stahl experiment using heavy nitrogen (¹⁵N) labeling. Each daughter duplex retains one parental strand and one newly synthesized strand. Replication begins at origins of replication (multiple in eukaryotes, single in prokaryotes), where the enzyme helicase unwinds the double helix, creating a replication fork. Single-stranded binding proteins (SSBs) stabilize the separated strands, while topoisomerase relieves the torsional strain ahead of the fork. Since all DNA polymerases synthesize in the 5′ → 3′ direction, the leading strand is synthesized continuously, while the lagging strand is synthesized discontinuously as short Okazaki fragments (~100–200 nucleotides in eukaryotes, ~1000–2000 in prokaryotes).

Key Enzymes at the Replication Fork

Enzyme	Function	Clinical Relevance
Helicase	Unwinds double helix at the replication fork (uses ATP hydrolysis)	Werner syndrome (WRN helicase mutation) → premature aging
Primase	Synthesizes short RNA primers (5–10 nucleotides) to provide a 3′-OH for polymerase	Required because DNA polymerase cannot initiate de novo synthesis
DNA Pol III (prokaryotes)	Primary replication polymerase; has 3′ → 5′ exonuclease (proofreading) activity	Target of some antibacterial agents; eukaryotic analogs are Pol δ (lagging) and Pol ε (leading)
DNA Pol I (prokaryotes)	Removes RNA primers (5′ → 3′ exonuclease) and fills gaps with DNA	Eukaryotic equivalent: RNase H removes primers; Pol δ fills gaps
DNA Ligase	Seals nicks by forming phosphodiester bonds between Okazaki fragments	DNA ligase IV deficiency → immunodeficiency (impaired V(D)J recombination)
Topoisomerase I / II	Relieves supercoiling; Topo I creates single-strand breaks, Topo II (gyrase) creates double-strand breaks	Pharmacological targets: fluoroquinolones (gyrase), etoposide (Topo II), irinotecan/topotecan (Topo I)
Telomerase	Reverse transcriptase that extends telomeric repeats (TTAGGG in humans) at chromosome ends	Reactivated in ~85% of cancers; dyskeratosis congenita from telomerase mutations

Summary of key replication enzymes, their functions, and clinical correlations

A common USMLE concept involves the end-replication problem. Because primase lays an RNA primer at the 5′ end of each Okazaki fragment, removal of the final primer on the lagging strand leaves an unrepaired gap that cannot be filled by any conventional DNA polymerase. With each cell division, telomeres shorten by approximately 50–200 base pairs. In somatic cells, progressive telomere attrition eventually triggers replicative senescence or apoptosis via p53-dependent pathways. Telomerase — active in germ cells, stem cells, and most cancer cells — mitigates this problem by adding TTAGGG repeats using an intrinsic RNA template, a concept classically tested on boards.

REPLICATION FIDELITY

Error rate ≈ 1 error per 10⁹ – 10¹⁰ nucleotides incorporated

This extraordinary fidelity results from three layers: (1) base selection by polymerase active site (~10⁵ accuracy), (2) 3′ → 5′ exonuclease proofreading (~10² improvement), and (3) post-replication mismatch repair (~10² – 10³ improvement). Together, they yield an overall error rate of ~10⁻⁹ to 10⁻¹⁰ per nucleotide per cell division.

SECTION 5

DNA Repair Pathways & Clinical Correlations

Despite the remarkable fidelity of replication, the human genome sustains an estimated 10,000–100,000 DNA lesions per cell per day from endogenous sources (reactive oxygen species, spontaneous depurination, deamination) and exogenous agents (UV radiation, alkylating chemotherapeutics, tobacco carcinogens). Multiple DNA repair pathways have evolved to identify and correct these lesions. Defects in these pathways are directly linked to cancer predisposition syndromes and are extensively tested on USMLE Step 1.

Overview of the six major DNA repair pathways. Each box lists the type of damage corrected, key enzymes, and associated clinical syndromes. The bottom panel summarizes high-yield disease associations frequently tested on USMLE Step 1.

Pathway Details

Base Excision Repair (BER) addresses small, non-helix-distorting lesions such as oxidized bases (8-oxoguanine), deaminated bases (uracil from cytosine deamination), or alkylated bases. A specific DNA glycosylase recognizes and cleaves the damaged base, creating an abasic (AP) site. An AP endonuclease then nicks the backbone, and the gap is filled by DNA polymerase β and sealed by DNA ligase III. A frequently tested concept: spontaneous deamination of cytosine produces uracil, which is recognized and removed by uracil-DNA glycosylase. However, deamination of 5-methylcytosine yields thymine — a normal base — making this lesion harder to detect and explaining why CpG dinucleotides are mutational hotspots.

Nucleotide Excision Repair (NER) corrects bulky, helix-distorting lesions such as pyrimidine dimers caused by UV-B radiation (cyclobutane pyrimidine dimers and 6-4 photoproducts) and benzo[a]pyrene adducts from cigarette smoke. A multiprotein complex recognizes the distortion, excises a 24–32 nucleotide oligomer containing the lesion, and DNA polymerase and ligase fill and seal the gap. Defects in NER cause xeroderma pigmentosum (XP), an autosomal recessive disorder conferring a >1000-fold increased risk of skin cancer. Patients must avoid all UV exposure — a classic clinical vignette on boards.

Mismatch Repair (MMR) corrects base–base mismatches and insertion/deletion loops that escape proofreading during replication. The key proteins are MSH2 (mismatch recognition) and MLH1 (coordinates excision). In prokaryotes, the parental strand is distinguished from the daughter strand by methylation of GATC sequences (the newly synthesized strand is transiently unmethylated). In eukaryotes, the mechanism of strand discrimination likely involves recognition of nicks in the nascent strand. Germline mutations in MMR genes cause Lynch syndrome (HNPCC), an autosomal dominant condition that predisposes to colorectal, endometrial, and ovarian cancers. Tumors show microsatellite instability (MSI) — expansion or contraction of short tandem repeat sequences — a hallmark tested both clinically and on examinations.

Double-strand breaks (DSBs) are the most lethal form of DNA damage and are repaired by two primary pathways. Nonhomologous end joining (NHEJ) operates throughout the cell cycle and directly ligates broken ends using the Ku70/Ku80 heterodimer and DNA-PKcs, though it is error-prone and may introduce small insertions or deletions. Homologous recombination (HR) is active only in S and G2 phases when a sister chromatid is available as a template, making it high-fidelity. BRCA1 and BRCA2 are essential for HR; loss-of-function mutations render cells dependent on alternative, error-prone repair pathways. This vulnerability is exploited clinically through PARP inhibitors (e.g., olaparib), which block single-strand break repair, forcing cells into HR — a lethal event in BRCA-deficient cells (synthetic lethality).

SECTION 6

Worked Example: Clinical Vignette Analysis

USMLE Step 1 frequently tests DNA repair through clinical vignettes. Let us walk through a representative question systematically.

A 7-year-old with severe sun sensitivity and multiple skin cancers

1
Step 1 — Identify Key Clinical Features

A 7-year-old child presents with extreme photosensitivity, freckling in sun-exposed areas, and two biopsy-proven squamous cell carcinomas on the face. Family history reveals consanguineous parents. The question asks: which DNA repair mechanism is most likely defective?
2
Step 2 — Recall the Damage Type

The clinical presentation centers on UV sensitivity and skin malignancies. UV-B radiation generates thymine (pyrimidine) dimers — covalent bonds between adjacent pyrimidines on the same strand. These are bulky, helix-distorting lesions.
3
Step 3 — Match Damage to Repair Pathway

BER handles small, non-distorting base changes. MMR corrects replication mismatches. DSB repair addresses strand breaks. Only nucleotide excision repair (NER) specifically corrects bulky, helix-distorting adducts by excising a 24–32 nucleotide segment containing the lesion.
4
Step 4 — Confirm with Inheritance Pattern

Consanguineous parents and early childhood onset suggest autosomal recessive inheritance — consistent with xeroderma pigmentosum (XP), caused by mutations in NER genes (XPA through XPG).
5
Step 5 — State the Answer and Eliminate Distractors

The defective mechanism is nucleotide excision repair. On the exam, common distractors include BER (small lesions only), mismatch repair (which would present with colorectal cancer, not skin cancers), and homologous recombination (BRCA mutations → breast/ovarian cancer).

Answer: Nucleotide Excision Repair (NER) — Xeroderma Pigmentosum

SECTION 7

Pharmacological Targeting of Replication & Repair

Many clinically important drugs exploit the replication and repair machinery as therapeutic targets. Understanding these connections is essential for both pharmacology and biochemistry sections of the USMLE. The table below organizes the major drug classes by their molecular targets within the replication and repair framework.

Drug / Class	Target	Mechanism	Clinical Use
Fluoroquinolones (ciprofloxacin)	Topoisomerase II (DNA gyrase)	Block resealing of double-strand breaks → bacterial DNA fragmentation	UTIs, respiratory infections, GI infections
Etoposide	Topoisomerase II (human)	Stabilizes cleavable complex → persistent DSBs → apoptosis	Testicular cancer, lymphomas, small cell lung cancer
Irinotecan / Topotecan	Topoisomerase I (human)	Stabilizes single-strand breaks → replication fork collapse	Colorectal cancer, ovarian cancer
PARP Inhibitors (olaparib)	Poly(ADP-ribose) polymerase	Blocks SSB repair → forces HR dependence → synthetic lethality in BRCA⁻/⁻ cells	BRCA-mutant breast/ovarian cancer
Nucleoside analogs (acyclovir, AZT)	DNA polymerase (viral)	Chain termination — lacks 3′-OH for next nucleotide addition	HSV (acyclovir), HIV (AZT/zidovudine)
Alkylating agents (cyclophosphamide)	DNA bases (cross-linking)	Interstrand cross-links prevent strand separation → replication arrest	Lymphomas, breast cancer, autoimmune diseases

Pharmacological agents targeting DNA replication and repair mechanisms

💊

CLINICAL PEARL

Synthetic lethality with PARP inhibitors is analogous to removing both the primary and backup power supplies from a hospital — if only one is knocked out, the building still functions. In BRCA-mutant cancer cells, homologous recombination (the 'primary generator') is already non-functional. Adding a PARP inhibitor disables BER-mediated single-strand break repair (the 'backup generator'), leaving the cell with no viable repair pathway — causing catastrophic genomic instability and cell death. Normal cells, with intact BRCA function, tolerate PARP inhibition because their 'primary generator' still works.

SECTION 8

Connections to Advanced Concepts: Epigenetics & Genomic Instability

The principles of DNA structure, replication, and repair form the foundation for several advanced topics you will encounter in pathology, oncology, and pharmacology. Epigenetic modifications — heritable changes in gene expression that do not alter the DNA sequence itself — operate directly on DNA structure. DNA methyltransferases add methyl groups to cytosine at CpG dinucleotides, converting cytosine to 5-methylcytosine. Hypermethylation of tumor suppressor gene promoters is a common mechanism of gene silencing in cancer, functionally equivalent to a loss-of-function mutation. Conversely, global hypomethylation may activate oncogenes and promote genomic instability.

Concept	Foundation (This Lesson)	Advanced Application
Replication fidelity	Proofreading + mismatch repair → ~10⁻⁹ error rate	Defects in POLE/POLD1 (proofreading exonuclease domain mutations) → ultramutated tumors responsive to immunotherapy
Telomere biology	End-replication problem, telomerase extends TTAGGG	Telomere crisis → chromosomal fusions → aneuploidy (hallmark of cancer); telomerase inhibition as anticancer strategy
CpG deamination	5-methylcytosine → thymine (undetected by BER)	CpG → TpG transitions are the most common point mutations in the human genome; explains CpG island evolution and p53 hotspot mutations
Microsatellite instability	MMR defects → repeat expansion/contraction	MSI-high tumors have high neoantigen load → respond to PD-1/PD-L1 checkpoint inhibitors (pembrolizumab)
NHEJ and V(D)J recombination	NHEJ machinery (Ku70/80, DNA-PKcs, Artemis) repairs DSBs	Same machinery mediates V(D)J recombination in lymphocytes; deficiency → SCID (Artemis mutation)

How foundational concepts connect to advanced clinical topics

As you progress through pathology and pharmacology, you will see these repair pathways reappear in the context of cancer biology, immunology, and targeted therapeutics. The shift from understanding how DNA is repaired to understanding what happens when repair fails — genomic instability, clonal evolution, and therapeutic vulnerability — represents one of the most clinically relevant bridges in all of molecular medicine.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A molecular biology student observes that when she heats a DNA sample, the two strands separate (denature). She finds that Sample A denatures at a higher temperature than Sample B. Which sample most likely has a higher GC content, and why?

Show answer

Sample A has a higher GC content. G-C base pairs are held together by three hydrogen bonds, whereas A-T base pairs have only two. More hydrogen bonds per base pair means more thermal energy is required to disrupt the interactions and separate the strands. Therefore, DNA with a higher percentage of GC base pairs will have a higher melting temperature (T_m). This principle is exploited in PCR primer design: primers with ~50–60% GC content tend to have optimal annealing temperatures for efficient amplification.

Question 2: BASIC CALCULATION

Analysis of a double-stranded DNA virus reveals that 20% of its bases are adenine. What are the percentages of thymine, guanine, and cytosine in this DNA?

Show answer

By Chargaff's rules, in double-stranded DNA, the percentage of adenine equals the percentage of thymine (A = T). Therefore, thymine = 20%. The remaining bases must account for 100% − 20% − 20% = 60% of total bases. Since G = C in double-stranded DNA, guanine = 30% and cytosine = 30%. This calculation is a direct application of Chargaff's first parity rule, which holds strictly for double-stranded DNA but not necessarily for single-stranded nucleic acids.

Question 3: INTERMEDIATE

A patient is diagnosed with Lynch syndrome (hereditary nonpolyposis colorectal cancer). Tumor analysis reveals a germline mutation in MSH2. The pathology report describes 'microsatellite instability-high (MSI-H).' Explain the molecular basis linking the MSH2 mutation to microsatellite instability, and name the specific DNA repair pathway that is defective.

Show answer

MSH2 is a critical component of the mismatch repair (MMR) pathway. During DNA replication, DNA polymerase occasionally slips at microsatellite regions — short tandem repeats such as (CA)ₙ — producing insertion or deletion loops (IDLs). Normally, the MSH2/MSH6 heterodimer (MutSα) recognizes these mismatches and recruits MLH1/PMS2 (MutLα) to coordinate excision and resynthesis of the error-containing strand. When MSH2 is non-functional, these replication errors persist, causing microsatellites to expand or contract with each cell division — the hallmark MSI-H phenotype. Clinically, MSI-H status in Lynch syndrome tumors has therapeutic implications: these tumors often respond favorably to immune checkpoint inhibitors (anti-PD-1 antibodies) because the high mutational burden generates neoantigens recognized by the immune system.

Question 4: APPLIED

A 45-year-old woman with BRCA1-mutant ovarian cancer is started on olaparib, a PARP inhibitor. Her oncologist explains that this drug exploits 'synthetic lethality.' Describe the molecular rationale for why olaparib selectively kills BRCA-deficient tumor cells while sparing normal cells.

Show answer

PARP (poly-ADP-ribose polymerase) detects and facilitates repair of single-strand breaks (SSBs) through the base excision repair pathway. When PARP is inhibited by olaparib, unrepaired SSBs are converted into double-strand breaks (DSBs) during replication fork progression. Normal cells repair these DSBs via homologous recombination (HR), a high-fidelity pathway that requires functional BRCA1 and BRCA2 proteins. In BRCA1-mutant tumor cells, HR is non-functional, so the cell cannot repair the accumulating DSBs. The cell attempts repair via error-prone NHEJ, but the resulting genomic catastrophe triggers apoptosis. Normal cells (heterozygous, retaining one functional BRCA1 allele) can still perform HR and tolerate PARP inhibition — this differential is the molecular basis of synthetic lethality. Two pathways are individually survivable when lost alone, but simultaneous loss of both is lethal.

Question 5: CRITICAL THINKING

Spontaneous deamination of cytosine produces uracil, which is efficiently removed by uracil-DNA glycosylase. However, spontaneous deamination of 5-methylcytosine produces thymine — a normal DNA base. Explain why CpG dinucleotides are mutational hotspots in the human genome, and discuss how this relates to the observation that CpG islands near gene promoters are relatively preserved in evolution despite this mutational pressure.

Show answer

When 5-methylcytosine (5mC) undergoes spontaneous deamination, it produces thymine rather than uracil. Unlike uracil, which is immediately recognized as foreign in DNA by uracil-DNA glycosylase, the resulting G:T mismatch contains two legitimate bases. Although a specific thymine-DNA glycosylase (TDG) exists in the BER pathway to address G:T mismatches at CpG sites, its efficiency is lower than uracil removal. Over evolutionary time, this leads to progressive CpG → TpG (and complementary CpA) transitions, depleting CpG dinucleotides throughout the genome. Interestingly, CpG islands — regions of high CpG density near gene promoters — are relatively preserved because they are typically unmethylated in the germline. Without methylation, deamination of cytosine yields uracil (not thymine), which is efficiently repaired by uracil-DNA glycosylase. Thus, the strong selective pressure to maintain regulatory sequences combined with the absence of methylation at these critical sites protects CpG islands from the mutational decay that affects the rest of the genome. This concept elegantly connects epigenetics, DNA repair, molecular evolution, and cancer biology — deamination of methylated CpG sites in the p53 gene, for example, accounts for a disproportionate fraction of oncogenic mutations across diverse cancer types.

SUMMARY

Lesson Summary

Summary

DNA is a double-stranded antiparallel helix in which complementary base pairing (A=T with 2 H-bonds; G≡C with 3 H-bonds) enables faithful information storage and transfer. Replication is semiconservative and proceeds bidirectionally from origins of replication. Helicase unwinds the helix, primase lays RNA primers, DNA polymerase synthesizes new strands in the 5′ → 3′ direction (continuously on the leading strand, discontinuously as Okazaki fragments on the lagging strand), and ligase seals the nicks. Topoisomerases relieve supercoiling, and telomerase addresses the end-replication problem at chromosome termini.

DNA repair pathways are critical for genomic stability. Base excision repair (BER) fixes small base lesions (oxidation, deamination). Nucleotide excision repair (NER) removes bulky helix-distorting adducts; its deficiency causes xeroderma pigmentosum. Mismatch repair (MMR) corrects replication errors; defects cause Lynch syndrome with microsatellite instability. Double-strand breaks are repaired by NHEJ (error-prone, all cell cycle phases) and homologous recombination (high-fidelity, S/G2 only); BRCA1/2 mutations impair HR and render tumors susceptible to PARP inhibitors via synthetic lethality. Pharmacological agents such as fluoroquinolones, etoposide, and nucleoside analogs target various components of the replication and repair machinery, underscoring the clinical importance of these biochemical pathways.